Interventional treatment of cancer pain

Seminars in Pain Medicine

Volumn 1, Issue 1, 2003, Pages 34-42

  Plancarte, Ricardo ^a   Alvarez, Jose ^b   Arrieta, Maria Christina ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Analgesia; Cancer pain; Neurolysis; Subarachnoid pumps

Indexed keywords

BACLOFEN; CLONIDINE; LOCAL ANESTHETIC AGENT; OPIATE; STEROID;

ADRENERGIC SYSTEM; ANALGESIA; ANESTHESIA DOLOROSA; AWARENESS; CANCER PAIN; CONFUSION; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; CRYOANESTHESIA; DRUG DELIVERY SYSTEM; DYSESTHESIA; ENDOSCOPY; GENERAL PRACTITIONER; HUMAN; HYPERALGESIA; HYPERESTHESIA; HYPERTHERMIC THERAPY; KYPHOPLASTY; LOCAL ANESTHESIA; NEUROLYSIS; PAIN; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL; PUMP; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEDATION; SURGICAL TECHNIQUE; TREATMENT FAILURE;

EID: 15744382256     PISSN: 15375897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-5897(03)00004-1     Document Type: Article

References (50)

1. Zekry HA, Bruera E: Regional pain syndromes in cancer patients. Curr Rev Pain 2000;4:179-186
2. Plancarte Sánchez R, Mille Loera JM, Velásquez Suárez R: Manejo intervensionista en el tratamiento del dolor por cáncer. Cancerología 1999;45:97-103
3. Organización Mundial de la Salud. Alivio del dolor por cáncer. Con una guía sobre la disposición de opioides (ed 2). Ginebra, Suiza: OMS, 1996
4. Fiels HL: Core curriculum for professional education in pain. Seattle, WA: IASP Press, 1995:59-62
5. US Department of Health and Trauma. Clinical practice guideline. Acute management: operative or medical procedures and trauma. Washington, DC (AHCPR 92-0032), US Department of Health Care Policy and Research, 1992
6. de Leon-Casasola OA: Postoperative pain management in patients with cancer. Is there more beyond pain control? in Mark L, Kirby R, Brown D (eds): Problems in anesthesia, cancer pain management. Philadelphia, Lippincott, 1993, pp 474-485
7. Ready LB, Ashburn M, Caplan RA: Practice guidelines for acute pain management in the perioperative setting. Anesthesiology 1995;82:1071-1081
8. Bonica JI, Buckley FP, Moricca C: Neurolytic blockade and hypophysectomy, in Bonica JI (ed): Management of pain (ed 2). Philadelphia, Lee and Febiger, 1990 p 1980
9. Ready LB, Edwards WT (eds): Management of acute pain: a practical guide. Seattle, WA: IASP Press, 1992
10. Patt RB: Pharmacotherapy, the cornerstone of the anesthesiologist's continued role in the treatment of cancer pain, in Mark L, Kirby R, Brown D. (eds) Problems in anesthesia. Cancer pain management Philadelphia, Lippincott, 1993 pp 486-508
11. Cousins MJ, Dwyerb GD: Chronic pain and neurolytic neural blockade, in Cousins MJ, Bridenbaugh PO (eds): Neural blockade (ed 2). Philadelphia, Lippincott, 1998 p 1053
12. Patt R, Plancarte R: Superior hypogastric plexus block: a new therapeutic approach for pelvic pain, in Interventional pain management. Philadelphia, Saunders, 1996, pp 384-391.
13. Plancarte R: Raquianestesia, in Aldrete IA (ed) Anestesiología teórico-práctica. Mexico City: Salvat, 1986 p 637
14. Walsh DT: Cancer pain, in Walsh DT (ed): Symptom control. Sydney, Blackwell Scientific, 1988, pp 329-365
15. Plancarte R, Velazquez SR: Palliative regional anestesia for hospitalized patients. Curr Opin Anesth 1994;7:444-447
16. Gerwin RD, Shannon S, Hong CZ: Inglater reliability in myofascial trigger point examination. Pain 1997;69:65-73
17. Iwama H, Akama Y: The superiority of Water-diluted 0.25% to neat 1% lidocaine for trigger-point injections in myofascial pain syndrome: a prospective randomized double-blind trial. Anesth Analg 2000;91:408-409
18. Abrams S: Neurolytic blocks of peripheral nerves, in Racz GB (ed): Techniques of neurolysis. Boston, Kluwer, 1989, p 185
19. Patt R: Peripheral neurolysis, in Patt R (ed): Cancer pain. Philadelphia, Lippincott, 1993, p 359
20. Plancarte R, Velazquez R, Patt RB: Cancer pain. Eur J Palliat Care 1993:377-425
21. Winnie AP: Neurolytic nerve blocks. Curr Rev Pain 1994;5:70-77
22. Plancarte R, Velezquez R, Patt R: Neurolytic blocks of sympathetic axis, in Patt R (ed) Cancer pain. Lippincott, 1993 pp 377-425.
23. Patt R, Plancarte R: Superior hypogastric plexus and ganglio impar, in Hahn MB, McQuillan PM, Sheplock GJ (eds): Regional anaesthesia: an atlas of anatomy and techniques. St Louis, MO, Mosby, 1996, pp 193-202
24. Patt R, Black RG. Cancer Bull 1995;47:52-60
25. Curley J, Castillo J, Hotz J, et al: Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996;84:1402-1421
26. Thomas S: Image-guided pain management. Philadelphia, Lippincott-Raven, 1997
27. Rosier RN: Orthopedic management of cancer pain, in Patt RB (ed): Cancer pain. Philadelphia, Lippincott, 1993, pp 461-468
28. Boas RA: The sympathetic nervous system and pain relief, in Swerdlow M, Chaiton JL (eds): Relief of intractable pain. Amsterdam, Elsevier, 1989, p 259
29. Raj PP, Ramamurthy S: Differential nerve block studies, in Raj PP (ed): Practical management of pain. Chicago, Year Book, 1986, p 173
30. Raj PP. Tratamiento práctico del dolor. Barcelona, Spain: Mosby/Doyma 1995:475-498
31. Bennett G: Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Sympt Manag 2000;20:537-543
32. Bedder MD, Burchiel K, Larson A: Cost analysis of two implantable narcotic delivery systems. J Pain Sympt Manag 1991;6:368-373
33. Anderson SR, Orbegozo M, Racz G, et al: Intrathecal granuloma in patients receiving high-dose intrathecal morphine therapy: a report of two cases. Pain Practice 2001;1:61-67
34. Lou L, Orbegozo M, King CL: Rational and techniques for single and multiple drug combinations in long-term intrathecal infusions. Pain Practice 2001;1:68-80
35. Myers DP, Lema MJ, de Leon-Casasola OA, et al: Interpleural analgesia for the treatment of severe cancer pain in terminally ill patients. J Pain Sympt Manag 1993;8:505-510
36. Lema MJ, Myers DP, de Leon Cassasola OA, et al: Pleural phenol therapy for the treatment of chronic esophageal cancer pain. Reg Anesth 1992;17:166-170
37. Cousins MJ: Anesthetic approaches in cancer pain, in Foley KM, Bonica JJ, Ventafridda V (eds): Advances in pain research and therapy. New York, Raven Press, 1988, vol 16:249-273
38. Plancarte R, Amezcua C, Patt R: Superior hypogastric plexus block forpelvic cancer pain. Anesthesiology 1990;73:236
39. de Leon Casasola OA: Superior hypogastric plexus block. Techn Reg Anesth Pain Manag 1997;1:27-31
40. Ewofford JB, Ratzman MD: Transarticular approach to blockade of the ganglion impar (ganglion of Walther). Reg Anesth Pain Med 1998;23:103 (suppl)
41. Plancarte SR, de Leon Casasola O, El-Helaly M, et al: Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth 1997;22:562-568
42. Plancarte SR. Nuevo abordaje percutáneo de los nervios esplácnicos. Madrid: Trabajo de Ingreso a la Academia Nacional de Medicina, 2000
43. Weil A: Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology 1996;199:241
44. Cotton A, Demondion X, Boutry N, et al: Therapeutic percutaneous injections in the treatment of malignant acetabular osteolyses. Radiographies 1999;19:647-653
45. Cotton A, Dewatre F, Cortet B, et al: Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methylmetacrylate at clinical follow-up. Radiology 1996;2000:525-530
46. Cotton A, Boutry N, Cortet B, et al: Percutaneous vertebroplasty state of art. Radiographics 1998;18:311-331
47. Weil A, Chiras J, Simon JM, et al: Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology 1996;199:241-247
48. Deramond H, Depriester C, Galibert P, et al: Percutaneous vertebroplasty with polymethylmetacrylate. Technique indications, and results. Radiol Clin N Am 1998;36:533-546
49. Anderson SR: Vertebroplasty. pain practice 2001;1:46-52
50. Smith TJ, Staats PS, Deer T, et al: Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain drug-related toxicity and survival. J Clin Oncol 2002;20:4040-4049